STAT+: Pharmalittle: Biden issues ’empty call’ for drug pricing reform; FDA threatens to fine company for not posting trial results

Top of the morning to you, and a fine one it is. Gray skies are hovering over the Pharmalot campus right now, but our spirits remain sunny, nonetheless. Why? We will trot out a bit of insight from the Morning Mayor, who would say ‘Every new day should be unwrapped like a precious gift.’ To celebrate the notion, we are brewing still more cups of stimulation and invite you to join us. Our choice today is vanilla caramel cream. Yum. Meanwhile, here are a few tidbits to help you on your journey today. With any luck, you will conquer the world. In any event, stay safe and stay in touch. …

Moderna (MRNA) plans to spend billions of dollars to boost production of Covid-19 vaccines and potentially triple its yearly output of doses in 2022, as the company seeks to meet rising global demand, The Wall Street Journal writes. The company said it could produce up to 3 billion doses of Covid-19 vaccines in 2022, compared with a projected output of up to 1 billion this year. Moderna said it would make no less than 800 million doses this year, up from a minimum 700 million it had forecast previously.

Continue to STAT+ to read the full story…